sorafenib,imatinib
novartis,bayer
['sorafenib', 'imatinib', 'sarcoma']
#esmo22 #sarcoma 25% disease control rate (sd 25%, cr+pr 0%) in cdkn2a neg rb1 pos #chordoma is this a hint for true anti-tumor activity? perhaps better in combination with tkis (ie imatinib, sorafenib)? 
24/7 optimism & enthusiasm in #sarcoma #GIST research and patient care at @VHIO | #SanidadPública | #SinCienciaNoHayFuturo | @MyEsmo Faculty. 
Tweets are my own